You have no items in your shopping cart.
Search results for: 'IL-17F'
97.40%
30.7 kDa (predicted)
20 μg, 100 μg, 200 μg, 500 μg96.30%
31 kDa (predicted)
500 μg, 200 μg, 100 μg- IL-17D Protein, Human, Recombinant [orb1961099]
Greater than 95% as determined by reducing SDS-PAGE.
20 KDa (reducing condition)
1 mg, 500 μg, 50 μg, 10 μg 17.5 /14.9 kDa (predicted). Due to glycosylation, the protein migrates to 23-28 kDa based on Tris-Bis PAGE result.
500 μg, 100 μg17.8 kDa (predicted). Due to glycosylation, the protein migrates to 30-35 kDa based on Tris-Bis PAGE result.
500 μg, 100 μg- IL-17F Protein, Mouse, Recombinant (His & Avi) [orb1960835]
> 95%
17.8 kDa (predicted). Due to glycosylation, the protein migrates to 30-35 kDa based on Tris-Bis PAGE result.
500 μg, 100 μg - IL-25/IL17E Protein, Human, Recombinant (His) [orb1962153]
SDS-PAGE: 100%; SEC-HPLC: 97%
20-26 KDa (reducing condition)
1 mg, 500 μg, 50 μg, 10 μg - IL-17F Protein, Human, Recombinant [orb1962167]
15 KDa (reducing condition)
1 mg, 500 μg, 50 μg, 10 μg - IL-17F Protein, Human, Recombinant (His) [orb1961713]
19 KDa (reducing condition)
1 mg, 500 μg, 50 μg, 10 μg